↓ Skip to main content

Cochrane Database of Systematic Reviews

Tirilazad for aneurysmal subarachnoid haemorrhage

Overview of attention for article published in Cochrane database of systematic reviews, February 2010
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
142 Mendeley
Title
Tirilazad for aneurysmal subarachnoid haemorrhage
Published in
Cochrane database of systematic reviews, February 2010
DOI 10.1002/14651858.cd006778.pub2
Pubmed ID
Authors

Shihong Zhang, Lichun Wang, Ming Liu, Bo Wu

Abstract

Delayed cerebral ischaemia is a significant contributor to poor outcome (death or disability) in patients with aneurysmal subarachnoid haemorrhage (SAH). Tirilazad is considered to have neuroprotective properties in animal models of acute cerebral ischaemia.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 142 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Brazil 1 <1%
Unknown 140 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 31 22%
Researcher 14 10%
Student > Ph. D. Student 13 9%
Student > Bachelor 13 9%
Student > Doctoral Student 9 6%
Other 28 20%
Unknown 34 24%
Readers by discipline Count As %
Medicine and Dentistry 62 44%
Nursing and Health Professions 12 8%
Neuroscience 12 8%
Agricultural and Biological Sciences 4 3%
Psychology 3 2%
Other 12 8%
Unknown 37 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2017.
All research outputs
#7,811,404
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#8,625
of 11,499 outputs
Outputs of similar age
#36,265
of 103,224 outputs
Outputs of similar age from Cochrane database of systematic reviews
#80
of 130 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 130 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.